About the Staff

Prof. Eyal Fenig brings decades of premier clinical and academic experience in oncology. He serves as the Head of the Radiotherapy Unit at the Davidoff Cancer Center, Beilinson Hospital (Rabin Medical Center), and is a Clinical Associate Professor at Tel Aviv University's Faculty of Medicine.

Prof. Fenig graduated with honors (Cum Laude) from the Technion Faculty of Medicine. He completed his oncology residency at Beilinson Hospital, followed by advanced fellowships and clinical research at world-renowned U.S. cancer centers:

• Clinical & Research Fellowship at the Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York (1992–1994).
• Advanced Training at the MD Anderson Cancer Center, Houston, Texas (1990–1991).

Throughout his academic and clinical practice, Prof. Fenig is deeply involved in clinical trials, advanced radiation therapies, and integrating innovative technologies to enhance patient outcomes.

Iris Tamir holds a Master's degree in Life Sciences and an MBA. Between 1996 and 2018, she led marketing and commercial operations across global pharmaceutical giants (Teva, AstraZeneca, Bayer), managing diverse therapeutic divisions. In 2012, she launched a first-of-its-kind digital application for inhaler instruction.

Personal Vision: "The metaphor that inspires me most is the children's tale of the golden heart flower... Just as the child journeys far to find the flower that can heal his mother, a clinical trial can be that rare golden blossom for a cancer patient. I am here to raise awareness about clinical trials and highlight the opportunities they provide."

Today, Iris spearheads business development and marketing at Trial-In Pharma, significantly expanding collaborations with patient advocacy organizations and medical centers.

Einav Bar is a certified Clinical Research Manager holding a Master’s degree in Emergency and Disaster Management from the University of Haifa. She gained valuable clinical experience as a study coordinator in the Hematology Department at Ichilov Hospital and as a research assistant at Johnson & Johnson.

Over 15 years in biotechnology R&D, Einav led pioneering synthetic biology and CRISPR projects presented at MIT, receiving prestigious recognition for innovation.

She brings a blend of rigorous scientific expertise, creativity, and dedication to advancing high-quality, patient-centric clinical research.

Mark serves as European Client Manager at Trial-In Pharma. As Vice President at EMAS, he manages the company's strategic collaborative efforts across the European continent.

He brings extensive experience in international business development, sales management, and market expansion, specializing in building long-term partnerships and bridging cultural environments to serve patient needs.

Teva Erez oversees the company's information systems and implements advanced automation pipelines to optimize operational workflows.

In his role, Teva ensures digital infrastructure remains secure, seamless, and dependable, crafting tech solutions that reduce administrative overhead and allow the team to focus on patient support.

Dolev Erez leads AI initiatives across the company, implementing innovative technologies to accelerate and enhance data analytics capabilities.

Dolev combines deep technical knowledge with sharp business acumen, harnessing machine learning to generate precise, rapid solutions for clients and healthcare partners.